📊 LFWD Key Takeaways
Is Lifeward Ltd. (LFWD) a Good Investment?
Lifeward demonstrates exceptional revenue growth (+1474% YoY) typical of early-stage medical device companies, but this is severely undermined by massive operating losses and negative cash burn of -3.7M annually against only 3.9M in revenue. With 11.4M in cash reserves, the company has approximately 3 years of runway, but the current operating model is unsustainable and there is no clear path to profitability.
Despite hypergrowth in revenue, Lifeward is deeply unprofitable with operating and net margins near -90% and a -$16.8M operating cash burn. With just $2.2M in cash, a sub-1 quick ratio, and limited debt capacity, near-term financing and dilution risk are high. Fundamentals need clear gross margin expansion and operating leverage before this becomes investable on fundamentals.
Lifeward Ltd. Key Strengths (LFWD)
- Explosive revenue growth of +1474% YoY indicates strong market demand and commercialization traction
- Healthy gross margin of 34.2% demonstrates efficient production and viable unit economics at the product level
- Strong liquidity position with 2.4x current ratio, 11.4M cash reserves, and minimal debt (0.06x D/E ratio) provides runway for operations
- Explosive top-line growth (+1473.9% YoY)
- Very low leverage with negligible long-term debt
- Asset-light with minimal capex and 38% gross margin
LFWD Stock Risks: Lifeward Ltd. Investment Risks
- Severe unprofitability with -263.5% operating margin; operating expenses are 7.2x revenue, indicating structural cost issues
- Negative operating cash flow of -3.7M annually combined with only 11.4M cash implies ~3 year survival window without profitability or funding
- Deeply negative shareholder returns (ROE -171.6%, ROA -32.3%) with -6.70 diluted EPS; company is in cash-burning phase with unproven path to sustainable profitability
- Acute liquidity risk given cash vs. burn
- Sustained negative FCF and -90% operating/net margins
- High probability of dilution or going-concern pressure
Key Metrics to Watch
- Operating cash flow trajectory and timeline to breakeven
- Quarterly cash burn rate relative to revenue growth rate to assess runway extension
- Operating margin expansion and gross margin sustainability as revenue scales
- Quarterly free cash flow (FCF)
- Gross and operating margin trajectory
Lifeward Ltd. (LFWD) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 2.40x current ratio provides a solid financial cushion.
LFWD Profit Margin, ROE & Profitability Analysis
LFWD vs Healthcare Sector: How Lifeward Ltd. Compares
How Lifeward Ltd. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Lifeward Ltd. Stock Overvalued? LFWD Valuation Analysis 2026
Based on fundamental analysis, Lifeward Ltd. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Lifeward Ltd. Balance Sheet: LFWD Debt, Cash & Liquidity
LFWD Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Lifeward Ltd.'s revenue has grown significantly by 224% over the 5-year period, indicating strong business expansion. The most recent EPS of $-31.13 indicates the company is currently unprofitable.
LFWD Revenue Growth, EPS Growth & YoY Performance
LFWD Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $443.0K | -$4.8M | $-5.53 |
| Q3 2025 | $1.2M | -$3.1M | $-0.20 |
| Q2 2025 | $900.0K | -$4.3M | $-0.50 |
| Q1 2025 | $500.0K | -$4.8M | $-0.46 |
| Q3 2024 | $1.6M | -$3.1M | $-0.35 |
| Q2 2024 | $988.0K | -$4.3M | $-0.50 |
| Q1 2024 | $489.0K | -$4.3M | $-0.51 |
| Q3 2023 | $290.0K | -$5.5M | $-0.09 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Lifeward Ltd. Dividends, Buybacks & Capital Allocation
LFWD SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Lifeward Ltd. (CIK: 0001607962)
📋 Recent SEC Filings
❓ Frequently Asked Questions about LFWD
What is the AI rating for LFWD?
Lifeward Ltd. (LFWD) has a Combined AI Grade of C from Claude (C) and ChatGPT (D) with 80% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are LFWD's key strengths?
Claude: Explosive revenue growth of +1474% YoY indicates strong market demand and commercialization traction. Healthy gross margin of 34.2% demonstrates efficient production and viable unit economics at the product level. ChatGPT: Explosive top-line growth (+1473.9% YoY). Very low leverage with negligible long-term debt.
What are the risks of investing in LFWD?
Claude: Severe unprofitability with -263.5% operating margin; operating expenses are 7.2x revenue, indicating structural cost issues. Negative operating cash flow of -3.7M annually combined with only 11.4M cash implies ~3 year survival window without profitability or funding. ChatGPT: Acute liquidity risk given cash vs. burn. Sustained negative FCF and -90% operating/net margins.
What is LFWD's revenue and growth?
Lifeward Ltd. reported revenue of $3.9M.
Does LFWD pay dividends?
Lifeward Ltd. does not currently pay dividends.
Where can I find LFWD SEC filings?
Official SEC filings for Lifeward Ltd. (CIK: 0001607962) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is LFWD's EPS?
Lifeward Ltd. has a diluted EPS of $-6.70.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is LFWD's fundamental grade?
Based on our AI fundamental analysis in May 2026, Lifeward Ltd. has a C grade with 80% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is LFWD stock overvalued or undervalued?
Valuation metrics for LFWD: ROE of -171.6% (sector avg: 15%), net margin of -275.1% (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is LFWD's AI grade for 2026?
Our dual AI analysis gives Lifeward Ltd. a combined C grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is LFWD's free cash flow?
Lifeward Ltd.'s operating cash flow is $-3.7M, with capital expenditures of $0.0. FCF margin is -93.7%.
How does LFWD compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin -275.1% (avg: 12%), ROE -171.6% (avg: 15%), current ratio 2.40 (avg: 2).